Less than four months after Monsanto’s board unanimously voted to reject the USD $62 billion acquisition bid by Bayer, the parties are again negotiating.

Bayer earlier described its offer as a “mutually compelling transaction”.

Monsanto, the US-based seed producer, has confirmed that German chemical and pharmaceutical giant, Bayer, has updated its offer to USD127.50 per share in cash, totalling approximately USD $65 billion.

At this early stage, both parties emphasise that there can be no assurance an acquisition will eventuate.

Monsanto is also examining other strategic possibilities in order to determine if a transaction is in the best interests of its shareholders.

Both companies are also long-established, Bayer more than 150 years of history, and Monsanto almost 120.

Monsanto is a seed producer and one of the world’s largest producers of genetically-modified (GM) crops as well as manufacturing herbicides and other related agricultural chemicals.

It its bid is accepted, Bayer will become the world’s largest producer of farming chemicals and seeds.

Share